DanHBarouchMD

Infectious Disease • Boston, MA

Professor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

Join to view full profile

Dr. Barouch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Barouch's full profile

Already have an account?

Office
330 Brookline Ave
Research East 113 Beth Israel Deaconess Hospital
Boston, MA 02215
Phone+1 617-667-4434

Fax+1 617-667-8210

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2001 - 2005
Harvard Medical SchoolClass of 2000

Certifications & Licensure

MA State Medical License 2001 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
Completed
Phase 1, Phase 2
Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults Start of enrollment: 2008 Feb 01
Completed
Phase 1
Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults Start of enrollment: 2009 Feb 08
Completed
Phase 1
Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults Start of enrollment: 2022 Apr 01
Recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

4 citations
COVID-19 vaccines: Immune correlates and clinical outcomes.
Shant H Mahrokhian, Lisa H Tostanoski, Samuel J Vidal, Dan H Barouch
Human Vaccines & Immunotherapeutics. 2024-12-31
Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques.
Joseph P Nkolola, David Hope, Ruoran Guan, Alessandro Colarusso, Malika Aid
Journal of Virology. 2024-12-17
Identification of a novel neutralization epitope in rhesus AAVs.
Gabriel Dagotto, Jana L Fisher, David Li, Zhenyu Li, Simon Jenni
Molecular Therapy. Methods & Clinical Development. 2024-12-12

Journal Articles

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Jerald Sadoff, Kathryn E Stephenson, Dan H Barouch, Macaya Douoguih, The New England Journal of Medicine

Lectures

11th Vaccines Research and Development: All Things Considered Conference
Global Technology Community (GTC), Boston, Massachusetts - 7/8/2013
Publisher Correction: Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys
Beth Israel Deaconess Hospital - Needham , Harvard Medical School ,Department Of Continuing Educatio - 5/30/2013

Press Mentions

WHO Approves First Mpox Diagnostic Test for Emergency UseOctober 7th, 2024
Mpox Vaccine Protection Fades Within 1 Year, Boosters NeededOctober 4th, 2024
Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic VaccinationOctober 3rd, 2024
Join now to see all

Grant Support

Consortium For AIDS Vaccine Research In Nonhuman PrimatesNational Institute Of Allergy And Infectious Diseases2011
AdministrativeNational Institute Of Allergy And Infectious Diseases2011
Adenovirus And Poxvirus Mediated Protection Against Mucosal SIV InfectionNational Institute Of Allergy And Infectious Diseases2011
Metagenomics Of Enteric Disease In Siv-Infected And Uninfected MacaquesNational Center For Research Resources2011
Impact Of HIV Envelope Conformation On ImmunogenicityNational Institute Of Allergy And Infectious Diseases2009–2011
Preclinical Evaluation Of Novel Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
Novel Heterologous Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
Novel Recombinant Adenovirus Vaccine Vectors For HIV/SIV In Rhesus MonkeysNational Center For Research Resources2005–2011
Novel Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2006–2010
Preclinical Evaluation Of Novel Adenovirus VectorsNational Institute Of Allergy And Infectious Diseases2005–2009
Novel Adenovirus Vector-Based Vaccines For HIV-1National Institute Of Allergy And Infectious Diseases2005–2009
Augmentation Of DNA Vaccine-Elicited Immunity To HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2008
AdministrativeNational Institute Of Allergy And Infectious Diseases2005
Chimeric Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2005
Cytokine-Augmented DNA Vaccine-Elicited Immunity To HIVNational Institute Of Allergy And Infectious Diseases2002–2005